Measure ID: MIPS 126|Diabetes|2026 Performance Year

Diabetes Mellitus: Diabetic Foot and Ankle Care Peripheral Neuropathy – Neurological Evaluation

Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who had a neurological examination of their lower extremities within 12 months.

ProcessDiabetesEndocrinologyFunctional Assessment

Last updated: January 15, 2026

⚙️

Measure Specification

Denominator (Eligible Population)

Patients aged ≥ 18 years on date of encounter
ANDDiagnosis for diabetes on date of encounter
ANDPatient encounter during the performance period
WITHOUTEncounters conducted via telehealth: M1426

Denominator Exclusions1

G2178Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure, for example patient bilateral amputee; patient has condition that would not allow them to accurately respond to a neurological exam (dementia, Alzheimer’s, etc.); patient has previously documented diabetic peripheral neuropathy with loss of protective sensation

Numerator

Patients who had a lower extremity neurological exam performed at least once within 12 months.

Submission Codes (QDCs)

✓ Performance Met
G8404Lower extremity neurological exam performed and documented
✗ Performance Not Met
G8405Lower extremity neurological exam not performed

Denominator Exceptions

G2179Denominator Exception: Clinician documented that patient had medical reason for not performing lower extremity neurological exam

🧮MIPS Score Simulator

Estimate only — actual CMS scoring may vary based on reporting method, data completeness, and annual rule updates.

%Benchmarks vary by collection type
💡 Tip: Enter your performance rate to compare MIPS points across all collection types. The same rate can score differently depending on how you submit.
VBCA Insights

💡Why This Measure Matters

This measure tracks whether diabetic patients receive regular neurological exams of their feet to detect early nerve damage before serious complications develop. Neuropathy is the leading cause of diabetic foot ulcers and amputations; early detection enables preventive care like proper footwear and foot care education. Test sensation using monofilament plus vibration or temperature annually in all diabetic patients. Refer to podiatry if abnormalities are found.

📖Clinical Rationale

Foot ulceration is the most common single precursor to lower extremity amputations among persons with diabetes. Treatment of infected foot wounds accounts for up to one-quarter of all inpatient hospital admissions for people with diabetes in the United States. Peripheral sensory neuropathy in the absence of perceived trauma is the primary factor leading to diabetic foot ulcerations.

Approximately 45-60% of all diabetic ulcerations are purely neuropathic. Other forms of neuropathy may also play a role in foot ulcerations. Motor neuropathy resulting in anterior crural muscle atrophy or intrinsic muscle wasting can lead to foot deformities such as foot drop, equinus, and hammertoes. In people with diabetes, 22.8% have foot problems such as amputations and numbness, compared with 10% of nondiabetics.

Over the age of 40 years old, 30% of people with diabetes have loss of sensation in their feet.

📝Clinical Recommendations

Recognizing important risk factors and making a logical, treatment-oriented assessment of the diabetic foot requires a consistent and thorough diagnostic approach using a common language. Without such a method, the practitioner is more likely to overlook vital information and to pay inordinate attention to less critical points in the evaluation. A useful examination will involve identification of key risk factors and assignment into appropriate risk category.

Only then can an effective treatment plan be designed and implemented.

📋Implementation Notes

This measure contains one strata defined by a single submission criteria. This measure produces a single performance rate. For the purposes of MIPS implementation, this patient-process measure is submitted a minimum of once per patient during the performance period. The most advantageous quality data code will be used if the measure is submitted more than once.

Evaluation of neurological status in patients with diabetes to assign risk category and therefore have appropriate foot and ankle care to prevent ulcerations and infections ultimately reduces the number and severity of amputations that occur.

Report this measure through VBCA

Our QCDR handles measure selection, data validation, and submission—so you can focus on clinical performance.

Learn About Our QCDR →
CPT only copyright 2025 American Medical Association. All rights reserved.